GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells

Pompe disease is a metabolic myopathy caused by deficiency of the acid α-glucosidase (GAA) enzyme and results in progressive wasting of skeletal muscle cells. The c.-32-13T>G (IVS1) GAA variant promotes exon 2 skipping during pre-mRNA splicing and is the most common variant for the childhood/adul...

Full description

Bibliographic Details
Main Authors: Erik van der Wal, Atze J. Bergsma, Tom J.M. van Gestel, Stijn L.M. in ‘t Groen, Holm Zaehres, Marcos J. Araúzo-Bravo, Hans R. Schöler, Ans T. van der Ploeg, W.W.M. Pim Pijnappel
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253117301403
id doaj-9f9c7d67ca804d6bbf6aabc1dbc487b8
record_format Article
spelling doaj-9f9c7d67ca804d6bbf6aabc1dbc487b82020-11-24T23:11:57ZengElsevierMolecular Therapy: Nucleic Acids2162-25312017-06-017C10111510.1016/j.omtn.2017.03.002GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle CellsErik van der Wal0Atze J. Bergsma1Tom J.M. van Gestel2Stijn L.M. in ‘t Groen3Holm Zaehres4Marcos J. Araúzo-Bravo5Hans R. Schöler6Ans T. van der Ploeg7W.W.M. Pim Pijnappel8Molecular Stem Cell Biology, Department of Clinical Genetics, Erasmus Medical Center, 3015 CN Rotterdam, the NetherlandsMolecular Stem Cell Biology, Department of Clinical Genetics, Erasmus Medical Center, 3015 CN Rotterdam, the NetherlandsMolecular Stem Cell Biology, Department of Clinical Genetics, Erasmus Medical Center, 3015 CN Rotterdam, the NetherlandsMolecular Stem Cell Biology, Department of Clinical Genetics, Erasmus Medical Center, 3015 CN Rotterdam, the NetherlandsDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, 48149 Münster, GermanyDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, 48149 Münster, GermanyDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, 48149 Münster, GermanyDepartment of Pediatrics, Erasmus Medical Center, 3015 CN Rotterdam, the NetherlandsMolecular Stem Cell Biology, Department of Clinical Genetics, Erasmus Medical Center, 3015 CN Rotterdam, the NetherlandsPompe disease is a metabolic myopathy caused by deficiency of the acid α-glucosidase (GAA) enzyme and results in progressive wasting of skeletal muscle cells. The c.-32-13T>G (IVS1) GAA variant promotes exon 2 skipping during pre-mRNA splicing and is the most common variant for the childhood/adult disease form. We previously identified antisense oligonucleotides (AONs) that promoted GAA exon 2 inclusion in patient-derived fibroblasts. It was unknown how these AONs would affect GAA splicing in skeletal muscle cells. To test this, we expanded induced pluripotent stem cell (iPSC)-derived myogenic progenitors and differentiated these to multinucleated myotubes. AONs restored splicing in myotubes to a similar extent as in fibroblasts, suggesting that they act by modulating the action of shared splicing regulators. AONs targeted the putative polypyrimidine tract of a cryptic splice acceptor site that was part of a pseudo exon in GAA intron 1. Blocking of the cryptic splice donor of the pseudo exon with AONs likewise promoted GAA exon 2 inclusion. The simultaneous blocking of the cryptic acceptor and cryptic donor sites restored the majority of canonical splicing and alleviated GAA enzyme deficiency. These results highlight the relevance of cryptic splicing in human disease and its potential as therapeutic target for splicing modulation using AONs.http://www.sciencedirect.com/science/article/pii/S2162253117301403myogenic progenitorsinduced pluripotent stem cellantisense oligonucleotidePompe diseaseIVS1 mutationskeletal muscle differentiationpre-mRNA splicingpseudo exonexon inclusionlysosomal storage disorder
collection DOAJ
language English
format Article
sources DOAJ
author Erik van der Wal
Atze J. Bergsma
Tom J.M. van Gestel
Stijn L.M. in ‘t Groen
Holm Zaehres
Marcos J. Araúzo-Bravo
Hans R. Schöler
Ans T. van der Ploeg
W.W.M. Pim Pijnappel
spellingShingle Erik van der Wal
Atze J. Bergsma
Tom J.M. van Gestel
Stijn L.M. in ‘t Groen
Holm Zaehres
Marcos J. Araúzo-Bravo
Hans R. Schöler
Ans T. van der Ploeg
W.W.M. Pim Pijnappel
GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
Molecular Therapy: Nucleic Acids
myogenic progenitors
induced pluripotent stem cell
antisense oligonucleotide
Pompe disease
IVS1 mutation
skeletal muscle differentiation
pre-mRNA splicing
pseudo exon
exon inclusion
lysosomal storage disorder
author_facet Erik van der Wal
Atze J. Bergsma
Tom J.M. van Gestel
Stijn L.M. in ‘t Groen
Holm Zaehres
Marcos J. Araúzo-Bravo
Hans R. Schöler
Ans T. van der Ploeg
W.W.M. Pim Pijnappel
author_sort Erik van der Wal
title GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
title_short GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
title_full GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
title_fullStr GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
title_full_unstemmed GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
title_sort gaa deficiency in pompe disease is alleviated by exon inclusion in ipsc-derived skeletal muscle cells
publisher Elsevier
series Molecular Therapy: Nucleic Acids
issn 2162-2531
publishDate 2017-06-01
description Pompe disease is a metabolic myopathy caused by deficiency of the acid α-glucosidase (GAA) enzyme and results in progressive wasting of skeletal muscle cells. The c.-32-13T>G (IVS1) GAA variant promotes exon 2 skipping during pre-mRNA splicing and is the most common variant for the childhood/adult disease form. We previously identified antisense oligonucleotides (AONs) that promoted GAA exon 2 inclusion in patient-derived fibroblasts. It was unknown how these AONs would affect GAA splicing in skeletal muscle cells. To test this, we expanded induced pluripotent stem cell (iPSC)-derived myogenic progenitors and differentiated these to multinucleated myotubes. AONs restored splicing in myotubes to a similar extent as in fibroblasts, suggesting that they act by modulating the action of shared splicing regulators. AONs targeted the putative polypyrimidine tract of a cryptic splice acceptor site that was part of a pseudo exon in GAA intron 1. Blocking of the cryptic splice donor of the pseudo exon with AONs likewise promoted GAA exon 2 inclusion. The simultaneous blocking of the cryptic acceptor and cryptic donor sites restored the majority of canonical splicing and alleviated GAA enzyme deficiency. These results highlight the relevance of cryptic splicing in human disease and its potential as therapeutic target for splicing modulation using AONs.
topic myogenic progenitors
induced pluripotent stem cell
antisense oligonucleotide
Pompe disease
IVS1 mutation
skeletal muscle differentiation
pre-mRNA splicing
pseudo exon
exon inclusion
lysosomal storage disorder
url http://www.sciencedirect.com/science/article/pii/S2162253117301403
work_keys_str_mv AT erikvanderwal gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT atzejbergsma gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT tomjmvangestel gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT stijnlmintgroen gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT holmzaehres gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT marcosjarauzobravo gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT hansrscholer gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT anstvanderploeg gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
AT wwmpimpijnappel gaadeficiencyinpompediseaseisalleviatedbyexoninclusioninipscderivedskeletalmusclecells
_version_ 1725603291730018304